The Effect of PTE Infusion in Hypomagnesemic States

  • M. Díaz Curiel
  • J. M. Castrillo
  • A. Rapado
  • P. Esbrit
  • M. Serrano
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 103)


The disorders of the parathyroid glands are probably the most frequent cause of hypocalcemia seen in hypomagnesemic states (1,2). The mechanisms reported in the literature are diverse: A) a defect in the secretion and/or formation of parathormone whose assessment by radioimmunoassay (iPTH) shows low serum levels, either absolute or relative to the degree of hypocalcemia (1, 3–5), and B) a failure in the peripheral action of the hormone (shown by the rise in iPTH) (6, 7) on the bone (8) and on the kidney, demonstrated by a deficient tubular response to the action of a parathyroid extract (PTE) (6, 9–11), measured by the tubular reabsorption of phosphate (TRP) and/or by the urinary excretion of cAMP.


Parathyroid Hormone Serum Magnesium Peripheral Action Serum Magnesium Level Parathyroid Gland Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rude, R.K., Oldham, S.B., and Singer, F.R.: Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin.Endocrinol. 5: 209, 1976CrossRefGoogle Scholar
  2. 2.
    Schneider, A.B., and Sherwood, L.M.: Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders. Metabolism 24: 871, 1975.PubMedCrossRefGoogle Scholar
  3. 3.
    Suh, S.M., Tashjian, A.H., Matsuo, N., Parkin, D.K., and Fraser, D.: Pathogenesis of hypocalcemia in primary hypomagnesemia. Normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. J.Clin.Invest. 52: 153, 1973.PubMedCrossRefGoogle Scholar
  4. 4.
    Anast, C.S.,Mohs, J.M., Kaplan, S.L., and Burns, T.W.: Evidence for parathyroid failure in magnesium deficiency. Science 177: 606, 1972.CrossRefGoogle Scholar
  5. 5.
    Anast, C.S., Winnacker, J.L., Forte, L.R. and Burns, T.W.: Impaired release of parathyroid hormone in magnesium deficiency. J.Clin.Endoc.Metab. 42: 707, 1976.CrossRefGoogle Scholar
  6. 6.
    Sherwood, L.M.: Magnesium ion and hypoparathyroid function. New Eng.J.Med. 282: 752, 1970.PubMedGoogle Scholar
  7. 7.
    Medalle, R., Waterhouse, C., and Hahn, T.J.: Vitamin D resistance in magnesium deficiency. Am.J.Clin.Nutr. 29: 854, 1976.PubMedGoogle Scholar
  8. 8.
    Muldowney, F.P., McKenna, J.S., Kyle, L.H., Freaney, R., and Swan, M.: Parathormone-like effect of magnesium replenishment in steatorrhea. New Engl.J.Med. 282: 61, 1970.PubMedCrossRefGoogle Scholar
  9. 9.
    Estep, H.L., Martínez, G.R., and Jones, D.: Parathyroid hormone (PTH) unresponsiveness and 3′,5′-cAMP secretion. Proc. 51st meet: of Endoc.Soc. New York, 1969.Google Scholar
  10. 10.
    Estep, H., Shaw, W.A., Watlington, C., Hobe, R., Holland, W., and Tucker, St G.: Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J, Cl in.Endocrinol.Metab. 29: 842, 1969.CrossRefGoogle Scholar
  11. 11.
    Ashby, J.P., and Heaton, F.W.: Effect of magnesium deficiency and parathyroid hormone on cyclic AMP metabolism in rat renal cortex. J.Endocrinol. 67: 105, 1975.PubMedCrossRefGoogle Scholar
  12. 12.
    Harrison, H.E., and Harrison, H.C.: The interaction of vitamin D and parathyroid hormone on calcium, phosphorus and magnesium homeostasis in the rat. Metabolism 13: 952, 1964.PubMedCrossRefGoogle Scholar
  13. 13.
    Rapado, A., Castrillo, J.M., Arroyo, M., Traba, M.L., and Calle, H.: Magnesium-deficient rickets. A clinical study. In: Vitamin D and problems related to uremic bone disease. Ed. by Norman, A.W., Schaefer, K., Grigoleit, H.G., v. Herrath, D., and Ritz, E. W. de Gruyter. Berlin, 1975.p. 453.Google Scholar
  14. 14.
    Hahn, T.J., Chase, L.R., and Avioli, L.U.: Effect of magnesium depletion on responsiveness to parathyroid hormone in parathyroidectomized rats. J.Clin.Invest. 51: 886, 1972.PubMedCrossRefGoogle Scholar
  15. 15.
    Reddy, C.R., Coburn, J.W., Hartenbower, D.L., Friedler, R. M., Brickman, A.S., Massry, S.G., and Jowsey, J.: Studies on mechanism of hypocalcemia of magnesium depletion. J.Clin.Invest. 52: 3000, 1973.PubMedCrossRefGoogle Scholar
  16. 16.
    Chase, L.R., and Slatopolsky, E.: Secretion and metabolic efficacy of PTH in patients with severe hypomagnesemia. J. Clin.Endocrin.Met. 38: 363, 1974.CrossRefGoogle Scholar
  17. 17.
    Rapado, A., and Castrillo, J.M.: Hypomagnesemia associated with nephrocalcinosis. Abstract of 2nd International Symposium on Magnesium. Montreal, 1976. p. 70.Google Scholar
  18. 18.
    Rapado, A., and Castrillo, J.M.: Primary hypomagnesemia with hypokalemia and alkalosis associated with chondrocalcinosis. Abstract of 2nd International Symposium on magnesium. Montreal, 1976. p. 71.Google Scholar
  19. 19.
    Henry, R.J.: Clinical Chemistry, Harper & Row Pub. New York, 1964. p. 148.Google Scholar
  20. 20.
    Fiske, C.H., and Subarow, Y.: The colorimetric determination of phosphorus. J.Biol.Chem. 66: 375, 1925.Google Scholar
  21. 21.
    Brown, B.L., Albano, J.D.M., Ekins, R.P., and Sgherzy, A.N.: A simple and sensitive saturation assay for measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J. 121: 561, 1971.PubMedGoogle Scholar
  22. 22.
    Arnaud, C.D., Tsao, H.S., and Littledike, T.: Radioimmunoassay of human parathyroid hormone in serum. J.Clin.Invest. 50: 21, 1971.PubMedCrossRefGoogle Scholar
  23. 23.
    Vainsel, M., Vandevelde, G., Smulders, J., Vosters, M., Hubain, P., and Loeb, H.: Tetany due to hypomagnesemia with secondary hypocalcemia. Arch.Dis.Child. 45: 254, 1970.PubMedCrossRefGoogle Scholar
  24. 24.
    Levi, J., Massry, S.G., Coburn, J.W., Llach, F., and Kleeman, C.R.: Hypocalcemia in magnesium-depleted dogs: evidence for reduced responsiveness to parathyroid hormone and relative failure of parathyroid gland function. Metabolism 23: 323, 1974.PubMedCrossRefGoogle Scholar
  25. 25.
    Drezner, M., Neelon, F.A., and Lebowitz, H.E.: Pseudohypoparathyroidism type II: A possible defect in the reception of the cyclic AMP signal. New Eng.J.Med. 289: 900, 1973.CrossRefGoogle Scholar
  26. 26.
    Norman, A.W., and Henry, H.: 1,25- dihydroxycholecalciferol. A hormonally active form of vitamin D. Rec.Prog.Horm.Res. 30: 431, 1974.PubMedGoogle Scholar
  27. 27.
    Paunier, L., Radde, I.C., Kooh, S.W., Coven, P.E., and Fraser, D.: Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 41: 385, 1968.PubMedGoogle Scholar
  28. 28.
    Gitelman, H.J., Graham, J.B., and Welt, L.G.A.: Familial disorders characterized by hypocaliemia and hypomagnesemia. Ann.New York Acad.Sci. 162: 856, 1969.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • M. Díaz Curiel
    • 1
  • J. M. Castrillo
    • 1
  • A. Rapado
    • 1
  • P. Esbrit
    • 1
  • M. Serrano
    • 1
  1. 1.Unidad Metabólica, Fundación Jiménez DíazUniversidad Autónoma de MadridSpain

Personalised recommendations